Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study.
John W MoroneyJohn PowderlyChristopher H LieuJohanna C BendellS Gail EckhardtChing-Wei ChangLuciana MolineroJessica SpahnPatrick WilliamsYvonne G LinF Stephen HodiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Atezolizumab plus bevacizumab led to durable responses and/or disease stabilization in some patients with platinum-resistant ovarian cancer; the safety profiles were consistent with those of each agent.
Keyphrases